These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2116659)
1. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel. Laurent C; Lamothe F; Develoux M; Sellin B; Mouchet F Trop Med Parasitol; 1990 Jun; 41(2):139-42. PubMed ID: 2116659 [TBL] [Abstract][Full Text] [Related]
2. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger]. Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149 [TBL] [Abstract][Full Text] [Related]
3. Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger. Heurtier Y; Lamothe F; Develoux M; Docquier J; Mouchet F; Sellin E; Sellin B Am J Trop Med Hyg; 1986 Nov; 35(6):1163-72. PubMed ID: 3098123 [TBL] [Abstract][Full Text] [Related]
4. Ultrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel. Devidas A; Lamothe F; Develoux M; Mouchet F; Sellin B Ann Soc Belg Med Trop; 1989 Mar; 69(1):57-65. PubMed ID: 2499278 [TBL] [Abstract][Full Text] [Related]
5. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel. Doehring E; Reider F; Schmidt-Ehry G; Ehrich JH J Infect Dis; 1985 Oct; 152(4):807-10. PubMed ID: 3930620 [TBL] [Abstract][Full Text] [Related]
6. Ultrasound Evolution of Pediatric Urinary Schistosomiasis after Treatment with Praziquantel in a Highly Endemic Area. Bocanegra C; Pintar Z; Mendioroz J; Serres X; Gallego S; Nindia A; Aznar ML; Soriano-Arandes A; Salvador F; Gil E; Sikaleta N; Moreno M; Molina I Am J Trop Med Hyg; 2018 Oct; 99(4):1011-1017. PubMed ID: 30141396 [TBL] [Abstract][Full Text] [Related]
7. [Significance of rapid evaluation indicators during the monitoring of graduated treatment against Schistosoma haematobium]. Chippaux JP; Campagne G; Garba A; Véra C Bull Soc Pathol Exot; 2001 Mar; 94(1):36-41. PubMed ID: 11346981 [TBL] [Abstract][Full Text] [Related]
8. Ultrasonography of ureteric abnormalities induced by Schistosoma haematobium infection before and after praziquantel treatment. Kardorff R; Traoré M; Doehring-Schwerdtfeger E; Vester U; Ehrich JH Br J Urol; 1994 Dec; 74(6):703-9. PubMed ID: 7827837 [TBL] [Abstract][Full Text] [Related]
9. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Hatz CF; Vennervald BJ; Nkulila T; Vounatsou P; Kombe Y; Mayombana C; Mshinda H; Tanner M Am J Trop Med Hyg; 1998 Nov; 59(5):775-81. PubMed ID: 9840596 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014 [TBL] [Abstract][Full Text] [Related]
11. [Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel]. Campagne G; Garba A; Barkiré H; Vera C; Sidiki A; Chippaux JP Trop Med Int Health; 2001 Jan; 6(1):24-30. PubMed ID: 11263461 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel. Hatz C; Mayombana C; de Savigny D; MacPherson CN; Koella JC; Degrémont A; Tanner M Trans R Soc Trop Med Hyg; 1990; 84(1):84-8. PubMed ID: 2111949 [TBL] [Abstract][Full Text] [Related]
13. [Efficacity of praziquantel in school-aged children in a hyperendemic zone for Schistoma haematobium (Niger, 1999)]. Garba A; Tohon Z; Sidiki A; Chippaux JP; de Chabalier F Bull Soc Pathol Exot; 2001 Mar; 94(1):42-5. PubMed ID: 11346982 [TBL] [Abstract][Full Text] [Related]
14. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin). Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection. Medhat A; Zarzour A; Nafeh M; Shata T; Sweifie Y; Attia M; Helmy A; Shehata M; Zaki S; Mikhail N; Ibrahim S; King C; Strickland GT Am J Trop Med Hyg; 1997 Jul; 57(1):16-9. PubMed ID: 9242311 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger. Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719 [TBL] [Abstract][Full Text] [Related]
17. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection. Doehring E; Ehrich JH; Bremer HJ Kidney Int; 1986 Oct; 30(4):582-5. PubMed ID: 3097374 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial. Barda B; Coulibaly JT; Hatz C; Keiser J PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149 [TBL] [Abstract][Full Text] [Related]